Have you ever taken an SGLT-2 inhibitor to help manage Type 1 diabetes?

Have you ever taken an sodium-glucose cotransporter 2 (SGLT-2)  inhibitor to help manage type 1 diabetes? SGLT-2 inhibitors are a class of oral medications which work by inhibiting the body’s productions of sodium-glucose transport proteins, which are the proteins that reabsorb glucose. Brand names include: Invokana, Farxiga and Jardiance.

Right now, SGLT-2 medications are approved by the FDA for use in type 2 patients—but many type 1 patients have used them off label to help with blood sugar management. A coalition of patient organizations including Beyond Type 1 are working together to bring patient perspectives to the FDA to inform future regulatory decisions. We need your input!